PROGRESSIVE B-CLL WITH HEPATIC-FAILURE - RESPONSE TO FLUDARABINE (FLU) AND BILIRUBIN PHARESIS

被引：0
|
作者：
PICKENS, P
SARIS, A
OBRIEN, C
机构：
[1] ABINGTON MEM HOSP,ABINGTON,PA 19001
[2] HOSP UNIV PENN,PHILADELPHIA,PA 19104
来源：
BLOOD | 1993年 / 82卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A575 / A575
页数：1
相关论文
共 50 条
  • [31] DECREASED DIURETIC RESPONSE TO FUROSEMIDE IN RATS WITH ACUTE HEPATIC-FAILURE
    HUANG, Y
    KAMIYA, A
    HAYASHI, Y
    INUI, K
    HORI, R
    JOURNAL OF PHARMACOBIO-DYNAMICS, 1988, 11 (08): : 583 - 589
  • [32] HEPATIC-FAILURE AFTER BONE-MARROW TRANSPLANTATION - RESPONSE
    BEELEN, DW
    QUABECK, K
    GRAEVEN, U
    SAYER, HG
    MAHMOUD, HK
    SCHAEFER, UW
    BLOOD, 1990, 75 (11) : 2265 - 2265
  • [33] Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin
    Shimoni, A
    Shvidel, L
    Klepfish, A
    Shtalrid, M
    Sigler, E
    Berrebi, A
    LEUKEMIA, 1999, 13 (01) : 142 - 143
  • [34] Immunomodulatory effects of chemotherapy for B-CLL (fludarabine, chlorambucil) on abnormal CD8+T cell subsets
    Bjork, RL
    Saven, A
    McDaniel, PR
    Bjork, RL
    CYTOMETRY, 2001, 46 (05): : 314 - 314
  • [35] Refractory pure red cell aplasia associated with B-CLL: successful treatment with a combination of fludarabine, cyclosporin A and erythropoietin
    A Shimoni
    L Shvidel
    A Klepfish
    M Shtalrid
    E Sigler
    A Berrebi
    Leukemia, 1999, 13 : 142 - 143
  • [36] Low-dose fludarabine increases rituximab cytotoxicity in B-CLL cells by triggering caspases activation in vitro
    Furlan, Anna
    Villanova, Federica
    Pietrogrande, Francesco
    Celadin, Marilena
    Sanzari, Mariella
    Vianello, Fabrizio
    LEUKEMIA & LYMPHOMA, 2010, 51 (01) : 107 - 113
  • [37] Evolution of a true B-cell chronic lymphocytic leukaemia (B-CLL) in a diffuse immunocytoma after treatment with fludarabine.
    Bernasconi, P
    Paulli, M
    Orlandi, E
    Perfetti, V
    Giardini, I
    Zibellini, S
    Vanelli, L
    Tenore, A
    Boni, M
    Cavigliano, PM
    Algarotti, A
    Brusamolino, E
    Lazzarino, M
    BLOOD, 2005, 106 (11) : 324B - 324B
  • [38] UCN-01 chemosensitizes human B-chronic lymphocytic leukemia (B-CLL) cells to the effects of fludarabine.
    Willis, C
    Byrd, JC
    Shinn, C
    Flinn, IW
    Grever, MR
    BLOOD, 1999, 94 (10) : 127A - 127A
  • [39] Involvement of p53 in α4β1 integrin-mediated resistance of B-CLL cells to fludarabine
    de la Fuente, MT
    Casanova, B
    Cantero, E
    del Cerro, MH
    Garcia-Marco, J
    Silva, A
    Garcia-Pardo, A
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 311 (03) : 708 - 712
  • [40] Greater in vivo B-CLL cell turnover is associated with progressive peripheral leukemic burden.
    Messmer, BT
    Messmer, D
    Allen, SL
    Rai, KR
    Hellerstein, M
    Chiorazzi, N
    BLOOD, 2003, 102 (11) : 926A - 926A
12345